HopeStage
Back to all studies
CompletedNCT05573906

Telehealth CBT during benzodiazepine taper for people taking opioids

About this titleRead the official source — NCT05573906

This study evaluated the effectiveness of cognitive behavioural therapy for people with anxiety.

Interventional studyAges 18–85United States
The study in practice

Understand this study

What did researchers investigate?

This study evaluated the effectiveness of cognitive behavioural therapy for people with anxiety.

Who was this study for?

Listed age limits: 18 years to 85 years.

Listed locations
Burbank and 2 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: April 13, 2023
Recruitment status
Completed
Enrollment listed in the registry
42
Sponsor
University of California, Los Angeles
Sponsor type
University
Study type
Drug
Intervention type
COMBINATION_PRODUCT
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 85 Years
Official registry ID
NCT05573906
Official title
Show the full official title

Augmenting the Efficacy of Benzodiazepine Taper With Telehealth-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Patients Using Prescription Opioids

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Burbank · Los Angeles · Santa Monica

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

This study evaluated the effectiveness of cognitive behavioural therapy for people with anxiety.

Who is behind this study?

The study sponsor is University of California, Los Angeles, a university.

Who was this study for?

Listed age limits: 18 years to 85 years.

Want to explore more studies?

Explore studies